R&D service

Custom model development

Develop a model and assay plan for specialized tissues, rare diseases or complex co-cultures, starting from the samples and endpoints available to your program.

Discuss custom development View the plan and evidence ↘

Early bright-field culture morphology and H&E histology in a human head and neck cancer tissue-derived organoid — Study data

Custom model studies

Build specialized models, then connect them to measurable phenotypes

Explore head and neck cancer culture, adipose differentiation, and GIST and osteosarcoma models through original imaging and tissue profiling.

Explore the experimental results

Study focus

Questions we can help answer

01How should the model strategy reflect the available samples?
02Which endpoints best address the current objective?
03How can model establishment support follow-on applications?

Study workflow

Build a model strategy around specialized samples and program goals

Custom development supports specialized tissues, rare diseases, complex co-cultures and new assays.

Representative work includes head and neck cancer organoid culture and histology, adipose differentiation and lipid accumulation, and pathology-guided mesenchymal tumor models. We design culture and assays around sample conditions, key phenotypes and intended use.

Objective and research priorities

Review sample source, disease or tissue features, existing methods and the intended question to identify the one or two endpoints that matter most.

Model and assay strategy

Configure samples and conditions around culture, cellular composition, key phenotype and assay window, creating a clear path to model expansion and follow-on applications.

Result review and optimization

Use prespecified criteria to plan follow-on work and optimize culture, controls, repeatability and assay methods.

Study expansion and transfer

Use project findings to expand samples or batches and document scope, SOP, QC criteria, raw data and recommendations for future use.

Study images and readouts

Establishment, differentiation and pathology in specialized models

Head and neck cancer culture morphology and H&E, adipose phenotypes before and after differentiation, and source-tissue/model comparisons in mesenchymal tumors show how specialized models are established, checked against source tissue and prepared for functional readouts. Efficacy, mechanism or co-culture studies can then be added for the program.

Bright-field morphology and Oil Red O staining before and after adipose organoid differentiation — 01
Adipose custom model: bright-field morphology and Oil Red O staining show a lipid-accumulation phenotype before and after differentiation, providing a measurable starting point for metabolic biology, lipid handling and candidate-response studies.
Study data

Two GIST morphology groups comparing tissue-derived cultures, source-tissue H&E and culture H&E — 02
Custom GIST models: bright-field culture morphology, source-tissue H&E and culture H&E compare spindle and mixed spindle/epithelioid patterns for case-specific pathology reference and model QC.
Study dataView the mesenchymal-tumor study

H&E, Vimentin, Ki67, SOX9 and TP53 profiling across osteosarcoma source tissue, PDO and primary tissue — 03
Custom osteosarcoma models: H&E and marker panels across source tissue, PDO and primary tissue compare identity, proliferation and lineage-associated phenotypes for downstream assay selection.
Study dataView the mesenchymal-tumor study

Expected study outputs

What you receive

Study data and findings

Experimental conditions, original images or data, QC results and an explanation of the findings.

Model application & reproducibility

A clear summary of what the model can assess, available assay options and the factors that affect model establishment and reproducibility.

Methods and follow-up plan

SOPs, QC guidance and a method report, together with a plan for the next study.

Relevant model systems

Study design

Programs can start from an established model or new samples, with a clear development path built around source material, primary endpoints and critical controls before extending into efficacy, mechanism, safety or method transfer.

For BBB, ADPKD and complex co-cultures, TRiCBIO builds from kidney organoid data, HUVEC–astrocyte co-culture, tight-junction imaging and permeability methods, then adds the disease phenotype, cell source and functional readouts the program requires.

FAQ

Planning your study

Explore model selection, study planning and deliverables before your first discussion with our scientists.

What can a custom organoid development project start from?

A project can start from an established model or from new tissue, cells or other suitable material. For the initial discussion, share the tissue or disease context, sample source, available methods or data, and the most important phenotype or assay objective. The team can then discuss culture, QC and follow-on applications.

How is custom model development staged and evaluated?

Development progresses through model establishment, characterization and functional testing. Each stage has clear objectives. We review the results with you and agree the next step in model optimization, assay development or sample expansion.

What is typically delivered from a custom development project?

Deliverables can include model and assay QC, original images and data, a method report, and agreed standard operating procedures (SOPs) and technical guidance. The report covers suitable applications, reproducibility and recommended next steps so your team can use or extend the work.

PROJECT DISCUSSION

Start with a focused project goal

A tissue or disease context, sample source and key phenotype or assay need are enough to begin. Together we can plan model establishment, QC and follow-on studies.

Start a study discussion See how we work ↗